Literature DB >> 6849266

Radionuclide analysis of peak filling rate, filling fraction, and time to peak filling rate. Response to supine bicycle exercise in normal subjects and patients with coronary disease.

G B Mancini, R A Slutsky, S L Norris, V Bhargava, W L Ashburn, C B Higgins.   

Abstract

Using gated equilibrium radionuclide angiography, variables of diastolic filling were analyzed at rest and during supine bicycle exercise in normal subjects (Group 1, n = 18), coronary patients with normal resting ejection fractions (Group 2, n = 26), and coronary patients with reduced resting ejection fractions (Group 3, n = 8). Indexes analyzed were peak filling rate and filling fraction during the first third of diastole. At rest, the peak filling rate was significantly lower in coronary patients than in normal subjects (3.18 +/- 0.82 end-diastolic volume [EDV]/s in Group 1 versus 2.41 +/- 0.66 EDV/s in Group 2, p less than 0.005; and 1.34 +/- 0.26 EDV/s in Group 3, p less than 0.001 versus Group 1). These differences persisted at peak exercise. Coronary patients also had significantly lower filling fractions at rest and during exercise than did normal control subjects. The time from end-systole to peak filling rate was longer at rest in patients in Group 2 (203 +/- 52 ms) than in subjects in Group 1 (172 +/- 50 ms, p less than 0.025). This remained true when the time to peak filling was normalized by the R-R interval. Although the exercise time to peak filling was longer in coronary patients in both Groups 2 and 3 than in Group 1, these differences were not apparent when the interval was normalized by the R-R interval. Thus, abnormalities in peak filling rate and filling fraction exist in patients with coronary disease both at rest and during exercise, but large overlaps exist between normal and coronary patients. Caution is advised in comparing the timing of events during diastole because apparent group differences may be related in part to rest or exercise heart rate.

Entities:  

Mesh:

Year:  1983        PMID: 6849266     DOI: 10.1016/s0002-9149(83)80009-5

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  18 in total

1.  Long term treatment with enalapril reduces plasma concentrations of macrophage colony stimulating factor in patients with coronary artery disease.

Authors:  K Sadamatsu; H Shimokawa; H Tashiro; K Yamamoto
Journal:  Heart       Date:  2001-10       Impact factor: 5.994

2.  Beta blockers enhance early diastolic filling in ischaemic heart disease: a radionuclide assessment.

Authors:  E Moralidis; G McCurrach; W Martin; I Hutton
Journal:  Heart       Date:  2001-10       Impact factor: 5.994

3.  Dilated cardiomyopathy and Chlamydia pneumoniae infection.

Authors:  H Song; H Tasaki; A Yashiro; K Yamashita; T Toyokawa; Y Nagai; H Takatsu; H Taniguchi; Y Nakashima
Journal:  Heart       Date:  2001-10       Impact factor: 5.994

4.  Equilibrium radionuclide angiocardiography.

Authors:  James R Corbett; Olakunle O Akinboboye; Stephen L Bacharach; Jeffrey S Borer; Elias H Botvinick; E Gordon DePuey; Edward P Ficaro; Christopher L Hansen; Milena J Henzlova; Serge Van Kriekinge
Journal:  J Nucl Cardiol       Date:  2006-11       Impact factor: 5.952

5.  Effects of atropine on left ventricular volumes and ejection and filling rates at rest and during exercise.

Authors:  H Kelbaek; J Marving; K Hvid-Jacobsen; S L Nielsen
Journal:  Br J Clin Pharmacol       Date:  1991-11       Impact factor: 4.335

6.  The role of nuclear medicine in assessments of cardiac dyssynchrony.

Authors:  Masanao Naya; Osamu Manabe; Kazuhiro Koyanagawa; Nagara Tamaki
Journal:  J Nucl Cardiol       Date:  2017-09-27       Impact factor: 5.952

7.  Computerized analysis of equilibrium radionuclide ventriculography time-activity curve in the assessment of left ventricular performance: comparison of two methods.

Authors:  G Zatta; G L Tarolo; B Palagi; R Picozzi; A Albertini; O Zoccarato
Journal:  Eur J Nucl Med       Date:  1985

8.  Effects of fenoldopam, a specific dopamine receptor agonist, on blood pressure and left ventricular function in systemic hypertension.

Authors:  M P Caruana; M Heber; G Brigden; E B Raftery
Journal:  Br J Clin Pharmacol       Date:  1987-12       Impact factor: 4.335

9.  Assessment of left ventricular function in coronary artery disease with the nuclear probe during intervention studies.

Authors:  A Lahiri; M J Bowles; R I Jones; J C Crawley; E B Raftery
Journal:  Br Heart J       Date:  1984-10

10.  Phase analysis of radionuclide angiography in acute myocardial infarction.

Authors:  D Bonaduce; G Morgano; M Petretta; P Arrichiello; R Breglio; S Betocchi; C Acampora; M Salvatore; M Chiariello
Journal:  Eur J Nucl Med       Date:  1990
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.